WuXi Biologics leases U.S. manufacturing facility

By The Science Advisory Board staff writers

June 9, 2020 -- Hong Kong-based WuXi Biologics has signed a 10-year lease for a clinical manufacturing facility in Cranbury, NJ, making it the company's third site in the U.S.

The company will install 6,000-L bioreactors for manufacturing, process development and quality control labs, and associated functional spaces. The 66,000-sq-ft facility is expected to open in late 2020 and will bring 100 new jobs to the region.

WuXi recently purchased land to build a 107,000-sq-ft facility in Worcester, MA, and leased a 33,000-sq-ft site for process development in King of Prussia, PA.

WuXi to build manufacturing facility in U.S.
WuXi Biologics announced it has signed a deal with Worcester Business Development to build a clinical and commercial manufacturing facility in Worcester,...

Copyright © 2020 scienceboard.net

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter